Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis

Table 1

Demographics and clinical characteristics of patients between two groups.

Variables	AR group ()	HC group ()	value
Sex			0.362
Male	54 (49.1%)	23 (57.5%)
Female	56 (50.9%)	17 (42.5%)
Age, years			0.287
BMI, kg/m^2			0.626
Smoking, yes/no	53/57	15/25	0.245
Drinking, yes/no	49/61	23/17	0.160
Baseline VAS	6.4 ± 1.4	0	<0.001
Baseline TNSS	8.8 ± 2.1	0	<0.001

AR: allergic rhinitis; HC: health control; BMI: body mass index; VAS: visual analogue scales; TNSS: total nasal symptoms score.